December 2016 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for December 2016. This roundup includes...
Lactobacillus Supplement Doesn’t Impact HbA1c in Type 2 Diabetes
Patients receiving highest dose of L. reuteri have increases in insulin sensitivity index versus baseline
Low Vitamin D Linked to Incident Frailty in Older Women
Correlation is attenuated after accounting for cardiometabolic diseases
Aqueous Humor VEGF Levels Up With Prostaglandin for Glaucoma
Findings for patients with diabetes, patients with glaucoma who used prostaglandin agents
Luseogliflozin Effective for T2DM With Low-Carb, High-Carb Diet
Similar efficacy when meals contain 40 to 55 percent total energy from carbohydrate
Aflibercept Rescues Vision After Laser for Diabetic Macular Edema
Improves visual and anatomic outcomes among eyes experiencing visual loss after laser DME treatment
Postprandial Hyperglycemia Linked to CVD Incidence in T2DM
Association with cardiovascular disease and mortality is independent of mean HbA1c level
More Years Lost for Whites Versus South Asians, Blacks With T2DM
Older South Asians with diabetes have longer life expectancy than South Asians without diabetes
Personal Health Care Spending Continues to Soar in the U.S.
Highest spending on diabetes, ischemic heart disease, and low back and neck pain in 2013
Chronic Hepatitis B Prevalence Higher in Those With T2DM
Findings based on comparison to adult-onset autoimmune diabetes, controls
